LIPOPHILIC HEXADENTATE ALUMINUM COMPLEXES OF NEW PHENOLATE-DERIVATIZED CYCLOHEXANETRIAMINE LIGANDS AND THEIR EFFECT ON THE PEPTIDE-TRANSPORT SYSTEM (PTS-1)

被引:32
作者
BOLLINGER, JE
MAGUE, JT
BANKS, WA
KASTIN, AJ
ROUNDHILL, DM
机构
[1] TULANE UNIV, DEPT CHEM, NEW ORLEANS, LA 70118 USA
[2] VET AFFAIRS MED CTR, NEW ORLEANS, LA USA
[3] TULANE UNIV, SCH MED, NEW ORLEANS, LA 70146 USA
关键词
D O I
10.1021/ic00112a029
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The compounds (RsalH(2))(3)tachH(3) (R = H, NO2, OMe) have been synthesized by Schiff base condensation between cis-1,3,5-triaminocyclohexane and a substituted salicylaldehyde, followed by reduction with KBH4. Reaction of these compounds with aluminum(III) salts gives uncharged hexacoordinate N3O3 complexes of type Al(RsalH(2))(3)-tach. The complexes have been characterized by a combination of infrared, H-1 and C-13{H-1} NMR, and mass spectroscopy. Structures of Al(salH(2))(3)tach and Al(NO2)(3)tach have been determined by X-ray crystallography. Al(salH(2))(3)tach: monoclinic, P2(1)/n, a = 15.047(2) Angstrom b = 11.355(1) Angstrom, c = 15.201(2) Angstrom, beta = 93.59(6)degrees, V = 2592(1) Angstrom(3), Z = 4, R = 0.038, R(w) = 0.052. Al(NO(2)salH(2))(3)tach: monoclinic, P2(1)/n, a = 12.305(1) Angstrom, b = 12.072(2) Angstrom, c = 20.229(3) Angstrom, beta = 90.26(1)degrees, V = 3005(1) Angstrom(3), Z = 4, R = 0.040, R(w) = 0.047. The partition coefficients between 1-octanol and water for the complexes Al(RsalH(2))(3)tach have the values 33.0, 9.0, and 4.4 for the derivatives with R = H, NO2,and OMe, respectively. We show that (NO(2)salH(2))(3)tachH(3) affects the action of aluminum on the peptide transport system (PTS-1).
引用
收藏
页码:2143 / 2152
页数:10
相关论文
共 64 条
[1]  
Martin R.B., Acc. Chem. Res., 27, (1994)
[2]  
Alfrey A.C., Mishell J.M., Burks J., Trans.-Am. Soc. Artif. Intern. Organs, 18, (1972)
[3]  
King S.W., Savory J., Wills M.R., CRC Crit. Rev. Clin. Lab. Sci., 14, (1981)
[4]  
Klatzo I., Wisniewski H., Streicher E., J. Neuropathol. Exp. Neurol., 24, (1965)
[5]  
Perl D.P., Gajdusek D.C., Gamito R.M., Yanagihara R.T., Gibbs C.J., Science, 217, (1982)
[6]  
Bowdler N.C., Beasley D.S., Fritze E.C., Goulette A.M., Hatton J.D., Hession J., Ostman D.L., Rugg D.J., Schmittdiel C.J., Pharmacol. Biochem. Behav., 10, (1979)
[7]  
Bugiani O., Ghetti B., Neurobiol. Aging, 3, (1982)
[8]  
Ebrina Y., Okada S., Hamazaki S., Midorikaura O., Toxicol. Appl. Pharmcol., 75, (1984)
[9]  
Crapper D.C., Dalton A.J., Physiol. Behav., 10, (1973)
[10]  
Wisniewski H.M., Kozlowski P.B., Ann. N.Y. Acad. Sci., 396, (1982)